Construct: ORF TRCN0000477069

Construct Description:

Construct Type:
ORF
Other Identifiers:
ORF012690.1_s317c1
Derived from:
ccsbBroadEn_11606
DNA Barcode:
ACGCCCCACAATGCCGACATTTAC
Epitope Tag:
V5
Notes:
No stop codon in insert

Originally Annotated References:

Gene:
RABL2A (11159)

Vector Information:

Vector Backbone:
pLX_317
Pol II Cassette 1:
SV40-PuroR
Pol II Cassette 2:
EF1a-TRCN0000477069
Selection Marker:
PuroR
Visible Reporter:
n/a
Epitope Tag:
V5

Current transcripts matched by this ORF:

Taxon Gene Symbol Description Transcript Nuc. Match %[?] Prot. Match %[?] Match Diffs[?]
1 human 11159 RABL2A RAB, member of RAS oncogene... NM_001306161.2 99.5% 98.7% 80T>C;305A>G
2 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354421.2 99.5% 98.7% 80T>C;305A>G
3 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354423.2 99.5% 98.7% 80T>C;305A>G
4 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003226.1 99.5% 98.7% 80T>C;305A>G
5 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354424.2 98.9% 98.1% 80T>C;216_217insGCA;302A>G
6 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354418.2 93.9% 93.1% 80T>C;305A>G;313_342del
7 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354419.2 93.9% 93.1% 80T>C;305A>G;313_342del
8 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003223.1 93.9% 93.1% 80T>C;305A>G;313_342del
9 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354416.2 72% 71% (many diffs)
10 human 11159 RABL2A RAB, member of RAS oncogene... NM_007082.5 72% 71% (many diffs)
11 human 11159 RABL2A RAB, member of RAS oncogene... NM_013412.4 72% 71% (many diffs)
12 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003220.1 72% 71% (many diffs)
13 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003222.1 72% 71% (many diffs)
14 human 11159 RABL2A RAB, member of RAS oncogene... NM_001306158.2 71.7% 71.1% 80T>C;217_408del;497A>G
15 human 11159 RABL2A RAB, member of RAS oncogene... NM_001306159.2 71.7% 71.1% 80T>C;217_408del;497A>G
16 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354412.2 71.7% 71.1% 80T>C;217_408del;497A>G
17 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354413.2 71.7% 71.1% 80T>C;217_408del;497A>G
18 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354414.2 71.7% 71.1% 80T>C;217_408del;497A>G
19 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003213.1 71.7% 71.1% 80T>C;217_408del;497A>G
20 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003214.1 71.7% 71.1% 80T>C;217_408del;497A>G
21 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003215.1 71.7% 71.1% 80T>C;217_408del;497A>G
22 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003216.1 71.7% 71.1% 80T>C;217_408del;497A>G
23 human 11159 RABL2A RAB, member of RAS oncogene... XM_024452575.1 71.7% 71.1% 80T>C;217_408del;497A>G
24 human 11158 RABL2B RAB, member of RAS oncogene... NM_001130922.3 71.6% 70.1% (many diffs)
25 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350005.2 71.6% 70.1% (many diffs)
26 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350006.2 71.6% 70.1% (many diffs)
27 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350007.2 71.6% 70.1% (many diffs)
28 human 11158 RABL2B RAB, member of RAS oncogene... NM_007081.4 71.6% 70.1% (many diffs)
29 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028556.1 71.6% 70.1% (many diffs)
30 human 11158 RABL2B RAB, member of RAS oncogene... NM_001003789.3 71.3% 70.3% (many diffs)
31 human 11158 RABL2B RAB, member of RAS oncogene... NM_001130919.3 71.3% 70.3% (many diffs)
32 human 11158 RABL2B RAB, member of RAS oncogene... NM_001130920.3 71.3% 70.3% (many diffs)
33 human 11158 RABL2B RAB, member of RAS oncogene... NM_001130921.3 71.3% 70.3% (many diffs)
34 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350003.2 71.3% 70.3% (many diffs)
35 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350004.2 71.3% 70.3% (many diffs)
36 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028552.1 71.3% 70.3% (many diffs)
37 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028555.1 71.3% 70.3% (many diffs)
38 human 11158 RABL2B RAB, member of RAS oncogene... XM_024452147.1 71.3% 70.3% (many diffs)
39 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354427.2 71.1% 57.9% (many diffs)
40 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003212.1 70.2% 69.2% (many diffs)
41 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003210.1 69.9% 69.3% (many diffs)
42 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003211.1 69.9% 69.3% (many diffs)
43 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028551.1 69.8% 68.3% (many diffs)
44 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350016.2 69.5% 68.5% (many diffs)
45 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350017.2 69.5% 68.5% (many diffs)
46 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354417.2 69.2% 68.5% (many diffs)
47 human 11159 RABL2A RAB, member of RAS oncogene... NM_001306160.3 69% 68% (many diffs)
48 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354410.2 69% 68% (many diffs)
49 human 11159 RABL2A RAB, member of RAS oncogene... XM_024452573.1 69% 68% (many diffs)
50 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354405.2 68.7% 68.2% (many diffs)
51 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354406.2 68.7% 68.2% (many diffs)
52 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354407.2 68.7% 68.2% (many diffs)
53 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354408.2 68.7% 68.2% (many diffs)
54 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354409.2 68.7% 68.2% (many diffs)
55 human 11159 RABL2A RAB, member of RAS oncogene... XM_006712208.3 68.7% 68.2% (many diffs)
56 human 11159 RABL2A RAB, member of RAS oncogene... XM_006712209.3 68.7% 68.2% (many diffs)
57 human 11159 RABL2A RAB, member of RAS oncogene... XM_011510509.2 68.7% 68.2% (many diffs)
58 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003203.1 68.7% 68.2% (many diffs)
59 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003204.1 68.7% 68.2% (many diffs)
60 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003205.1 68.7% 68.2% (many diffs)
61 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003207.1 68.7% 68.2% (many diffs)
62 human 11158 RABL2B RAB, member of RAS oncogene... NM_001130923.3 68.6% 67.2% (many diffs)
63 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350013.2 68.6% 67.2% (many diffs)
64 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350014.2 68.6% 67.2% (many diffs)
65 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350015.2 68.6% 67.2% (many diffs)
66 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028547.1 68.6% 67.2% (many diffs)
67 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354426.2 68.5% 53.7% (many diffs)
68 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350008.2 68.3% 67.3% (many diffs)
69 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350009.2 68.3% 67.3% (many diffs)
70 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350010.2 68.3% 67.3% (many diffs)
71 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350011.2 68.3% 67.3% (many diffs)
72 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350012.2 68.3% 67.3% (many diffs)
73 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028543.1 68.3% 67.3% (many diffs)
74 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028544.1 68.3% 67.3% (many diffs)
75 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028546.1 68.3% 67.3% (many diffs)
76 human 11159 RABL2A RAB, member of RAS oncogene... XM_024452576.1 67.2% 54.8% (many diffs)
77 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354428.2 67% 58.2% (many diffs)
78 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354425.2 64.8% 51% (many diffs)
79 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003230.1 64.8% 51% (many diffs)
80 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028559.2 58.4% 47.3% (many diffs)
81 human 11159 RABL2A RAB, member of RAS oncogene... NR_148880.2 25% (many diffs)
82 human 11159 RABL2A RAB, member of RAS oncogene... NR_148879.2 24.3% (many diffs)
83 human 11159 RABL2A RAB, member of RAS oncogene... NR_148882.2 24.2% (many diffs)
84 human 11159 RABL2A RAB, member of RAS oncogene... NR_148881.2 24.2% (many diffs)
85 human 11159 RABL2A RAB, member of RAS oncogene... XR_002959036.1 19.7% (many diffs)
86 mouse 68708 Rabl2 RAB, member RAS oncogene fa... XM_006521327.3 46.1% 43.6% (many diffs)
Download CSV

Sequence Information

Note: uppercase bases indicate empirically verified sequence.

ORF start:
69
ORF end:
564
ORF length:
495
Sequence:
1tcttccattt caggtgtcgt gaggctagca tcgattgatc aacaagtttg tacaaaaaag
61ttggcaccat ggcagaagac aaaaccaaac cgagtgagtt ggaccaaggg aagtatgatg
121ctgatgacaa cgtgaagatc atctgcccgg gagacagcgc agtgggcaaa tccaaactca
181tggagagatt tctcatggat ggctttcagc cacagcagct gtccacgtac gcccTGACCC
241TGTACAAGCA CACAGCCACG GTAGATGGCA AGACCATCCT TGTGGCAGAC ATAAACGTGA
301CCCAAAAAAG CTTCAATTTT GCCAAGAAGT TCTCCCTGCC CCTGTATTTC GTCTCGGCTG
361CTGATGGTAC CAGTGTTGTG AAGCTCTTCA ATGATGCAAT TCGATTAGCT GTGTCTTACA
421AACAGAACTC CCAGGACTTC ATGGATGAGA TTTTTCAGGA GCTCGAGAAC TTCAGCTTGG
481AGCAGGAAGA GGAGGACGTG CCAGACCAGG AACAGAGCAG CAGCATCGAG ACCCCATCAG
541AGGAGGTGGC CTCTCCCCAC AGCTTGCCAA CTTTCTTGTA CAAAGTGGTT GATATCGGTA
601AGCCTATCCC TAACCCTCTC CTCGGTCTCG ATTCTACGTA GTAATGAACT AGTCCGTAAC
661TTGAAAGTAT TTCGATTTCT TGGCTTTATA TATCTTGTGG AAAGGACGAA CGCCCCACAA
721TGCCGACATT TACACGCGTT AAGTCgacaa tcaacctctg gattacaaaa tttgtgaaag
781att

Download FASTA (ORF) (Full)